首页 | 本学科首页   官方微博 | 高级检索  
     

喘可治注射液雾化吸入治疗支气管哮喘的有效性及安全性的系统评价
引用本文:段元元,吕健,王志飞,于丹丹,孙梦华. 喘可治注射液雾化吸入治疗支气管哮喘的有效性及安全性的系统评价[J]. 世界中医药, 2021, 16(2): 268-273
作者姓名:段元元  吕健  王志飞  于丹丹  孙梦华
作者单位:中国中医科学院中医临床基础医学研究所,北京,100700;中国中医科学院广安门医院,北京,100091;中国中医科学院中医临床基础医学研究所,北京,100700
基金项目:国家重点研发计划项目(2018YFC1707400,2018YFC1707410)
摘    要:目的:系统评价喘可治注射液雾化吸入治疗支气管哮喘的疗效和安全性.方法:计算机检索Embase、Cochrane Li-brary、CBM、CNKI、Medline、维普中文科技期刊全文数据库(VIP)和万方数据资源系统,筛选出喘可治注射液治疗支气管哮喘的随机对照试验,检索时限均为从建库至2019年4月.按照纳入和排除标...

关 键 词:喘可治注射液  支气管哮喘  系统评价  循证医学  Meta分析
收稿时间:2019-10-10

Efficacy and Safety of Aerosol Inhalation of Chuankezhi Injection for Bronchial Asthma:a Systematic Review and Meta-analysis
DUAN Yuanyuan,LYU Jian,WANG Zhifei,YU Dandan,SUN Menghua. Efficacy and Safety of Aerosol Inhalation of Chuankezhi Injection for Bronchial Asthma:a Systematic Review and Meta-analysis[J]. World Chinese Medicine, 2021, 16(2): 268-273
Authors:DUAN Yuanyuan  LYU Jian  WANG Zhifei  YU Dandan  SUN Menghua
Affiliation:(Institute of Basic Medical Sciences,China Academy of Traditional Chinese Medicine,Beijing 100700,China;Guang Anmen Hospital,China Academy of Traditional Chinese Medicine,Beijing 100091,China)
Abstract:Objective:To systematically assess the effectiveness and safety of aerosol inhalation of Chuankezhi Injection for the treatment of bronchial asthma.Methods:Databases including Embase,Cochrane Library,SinoMed,CNKI and Wanfang Data were electronically searched in April 2019 for randomized controlled trials(RCTs)on Chuankezhi Injection for the treatment of bronchial asthma.According to the inclusion and exclusion criteria,2 authors independently conducted literature screening and data extraction,and assessed the risk of bias of included studies.Then,meta-analysis was performed by RevMan 5.3 software.Results:A total of 9 RCTs were included with a total of 842 patients.Among them,there were 421 cases in the test group and 421 cases in the control group.Meta-analysis results showed:1)In terms of effectiveness,the total effective rate of Chuankezhi Injection aerosol inhalation combined with conventional treatment for bronchial asthma intervention(RR=1.22,95%CI[1.15,1.29],P<0.00001).The actual value of lung function FEV1 accounted for the percentage improvement of the predicted value(MD=6.03,95%CI[4.23,7.84],P<0.00001).The actual basic test value of FEV1(MD=0.44,95%CI[0.32,0.56],P<0.00001).The actual PEF value of lung function as a percentage of the predicted value(MD=6.03,95%CI[4.23,7.84],P<0.00001),the actual basic test value of FEV1(MD=0.58,95%CI[0.36,0.80],P<0.00001)is better than conventional treatment alone;2)in terms of safety,the incidence of adverse reactions of Chuankezhi Injection combined with conventional treatment for bronchial asthma is not statistically significant compared with conventional treatment(RR=0.59,95%CI[0.26,1.35],P=0.21).Conclusion:Based on the existing clinical evidence,the effect of aerosol inhalation of Chuankezhi Injection combined with conventional treatment for bronchial asthma is better than conventional treatment alone.However,because the methodological quality of the included studies is generally low,follow-up clinical studies also require strict methodological design and quality control in order to provide higher-quality evidence.
Keywords:Chuankezhi Injection   Bronchial asthma   Systematic review   Evidence-based medicine   Meta-analysis
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号